Alfresa Holdings to Enhance Governance with New Committee Structure

An announcement from Alfresa Holdings ( (JP:2784) ) is now available.

Alfresa Holdings Corporation announced plans to transition to a company with an audit and supervisory committee structure, pending approval at the upcoming Ordinary General Meeting of Shareholders. This change aims to enhance corporate governance and decision-making efficiency by strengthening board monitoring functions and delegating business execution authority to directors.

The most recent analyst rating on (JP:2784) stock is a Hold with a Yen2120.00 price target. To see the full list of analyst forecasts on Alfresa Holdings stock, see the JP:2784 Stock Forecast page.

More about Alfresa Holdings

The Alfresa Group is a prominent entity in the Japanese healthcare sector, focusing on ethical and OTC pharmaceuticals wholesaling, pharmaceutical manufacturing, and operating dispensing pharmacies. They reported a consolidated revenue of ¥2.9 trillion for the fiscal year ending March 31, 2025.

Average Trading Volume: 511,221

Technical Sentiment Signal: Strong Buy

Current Market Cap: Yen414.9B

See more insights into 2784 stock on TipRanks’ Stock Analysis page.